Cypress Capital Management (Wyoming)’s Zimmer Biomet ZBH Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-103	Closed	-$12K	–	335
2017 Q3	$12K	Hold	103	–	–	0.01%	205
2017 Q2	$12.8K	Hold	103	–	–	0.01%	192
2017 Q1	$12.2K	Sell	103 -103	-50%	-$11.7K	0.02%	203
2016 Q4	$20.7K	Hold	206	–	–	0.02%	176
2016 Q3	$26K	Hold	206	–	–	0.03%	140
2016 Q2	$24.1K	Hold	206	–	–	0.03%	135
2016 Q1	$21.3K	Hold	206	–	–	0.03%	142
2015 Q4	$20.5K	Hold	206	–	–	0.03%	149
2015 Q3	$18.8K	Sell	206 -206	-50%	-$20.7K	0.02%	157
2015 Q2	$43.7K	Hold	412	–	–	0.05%	137
2015 Q1	$47K	Hold	412	–	–	0.06%	121
2014 Q4	$45.4K	Buy	+412	New	+$43.4K	0.06%	106

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s ZBH Position: Q4 2017 in Review

Cypress Capital Management (Wyoming) sold out of Zimmer Biomet (ZBH) in Q4 2017, closing a stake of 103 shares — an estimated $12K sold.

Cypress Capital Management (Wyoming) first reported a position in ZBH in Q4 2014 and held it in 12 quarters. The position peaked at $47K in Q1 2015. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

Cypress Capital Management (Wyoming) reported no remaining Zimmer Biomet position as of Q4 2017 after selling out during the quarter.
Cypress Capital Management (Wyoming) sold 103 Zimmer Biomet shares in Q4 2017, an estimated $12K.
Cypress Capital Management (Wyoming) first reported a position in Zimmer Biomet in Q4 2014 and held it in 12 quarters.
Cypress Capital Management (Wyoming)'s Zimmer Biomet position peaked at $47K in Q1 2015.
870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q4 2017, filed 31 Jan 2018.